Hulamin (HLM) H2 2025 earnings summary

Executive summary

• Completed a three-year strategic capital program, including the wide canbody project and exit from non-core operations, despite short-term operational setbacks and a 25-day planned shutdown.

• Operational disruptions, including plant instability and equipment failure, temporarily reduced capacity and output, impacting profitability and liquidity.

• Remedial actions stabilized plant performance by year-end, with production expected to return to normal levels in early 2026.

Financial highlights

• Revenue rose 2% to ZAR 13.1 billion despite a 2% decrease in volumes, driven by higher LME pricing and improved geo-market premiums.

• Normalized EBIT declined by 77% year-over-year due to currency strength and operational challenges.

• Cash generated from operating activities more than doubled, supported by improved working capital conversion.

• Net debt increased 24% to ZAR 1.6 billion after elevated CapEx, but all debt covenants were met.

• Normalized headline loss of ZAR 85 million for the year, with normalized EBITDA at ZAR 261 million after non-recurring losses.

Outlook and guidance

• Production expected to ramp up to normal levels by end of Q1 2026, targeting 200,000 annualized tons.

• Focus on reducing net debt, lowering interest costs, and extracting value from recent capital investments.

• Additional ZAR 150 million in sustainable cost reductions targeted for 2026.

• No rights issue planned; debt reduction to be achieved through improved cash generation and working capital management.